Emerald Health Pharmaceuticals Granted European Orphan Designation for Systemic Scleroderma - Press Release
Digital Journal,
SAN DIEGO, CA / ACCESSWIRE / February 15, 2018 / Emerald Health Pharmaceuticals Inc.
SAN DIEGO, CA / ACCESSWIRE / February 15, 2018 / Emerald Health Pharmaceuticals Inc.
/ Emerald Health Pharmaceuticals Inc. (“EHP”), which is developing medicines based on cannabinoid science, today announced that…
Study Published in Journal of Neuroinflammation Indicates the Potential of EHP-102, a New Molecular Entity Derived from…